Population Pharmacokinetic and Exposure‐Response Analyses of Ibrutinib Combined With Bendamustine and Rituximab in Patients With Mantle Cell Lymphoma.
Saved in:
| Title: | Population Pharmacokinetic and Exposure‐Response Analyses of Ibrutinib Combined With Bendamustine and Rituximab in Patients With Mantle Cell Lymphoma. |
|---|---|
| Authors: | Gisleskog, Per Olsson1 (AUTHOR), Valenzuela, Belén2 (AUTHOR), Treijtel, Nicoline2 (AUTHOR), Deshpande, Sanjay3 (AUTHOR), Henninger, Todd3 (AUTHOR), Perez‐Ruixo, Juan José2 (AUTHOR) jjperezr@its.jnj.com |
| Source: | CPT: Pharmacometrics & Systems Pharmacology. Oct2025, Vol. 14 Issue 10, p1562-1574. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
